americanpharmaceuticalreviewAugust 12, 2021
Tag: American Injectables , Adam Levitt , Alison Brown
American Injectables Inc., a developer and manufacturer of sterile injectable parenteral drugs located in Tampa Bay, FL announced the expansion of the leadership team with the hiring of Adam Levitt as CEO, Gilad Shadur as CFO and Alison Brown as VP Quality, further strengthening the leadership team after the addition of Ben Boling as COO last year.
Adam Levitt becomes the CEO effective 1 August 2021. Adam was already a board member for the company, making this a smooth leadership transition. Adam will have strategic and operational responsibility for American Injectables and will report to the board of directors. Prior to joining, Adam was CEO, Shilpa Pharma Inc., the US arm of Shilpa Medicare Ltd., a global API and Formulation company. He previously held executive roles with Teva Pharmaceuticals, Strides/Agila, Perrigo and Dr. Reddy's. Adam brings extensive experience and leadership to the company at a key time in its growth.
Gilad Shadur joined American Injectables in May 2021 and assumes full responsibility for the financial management of the company, including IT. He will report to the CEO. Most recently, Gilad was CFO, R&D and Portfolio at Teva Pharmaceuticals. Previously he held a similar position with Teva leading finance activities for the US Generics business. These and other roles were the result of many successful years advancing through various assignments in the finance organization.
Alison Brown also joined American Injectables in August 2021. Alison will be responsible for Quality Assurance and Compliance, ensuring Good Manufacturing Practices as they pertain to regulatory governing bodies for products produced at American Injectables. She will report to the CEO. Alison joins the company having held previous senior roles in Quality site leadership, and a career of over 25 years' experience in the pharmaceutical industry.
The new hires together with Ben Boling, COO and Travis Allen, VP Operations/Business Development form a seasoned and talented leadership team bringing to American Injectables world-class experience from Teva, Perrigo, Dr. Reddy's, AMRI, Bayer and Amgen.
Mr. Levitt commented, "I am very excited about the team we have built and the strategy for the Company. Assuring Essential Medicines are available for all patients is paramount to securing our health care system's independence from supply chain issues and shortages. Gaining access to our first ANDA, demonstrates the company's readiness and commitment to manufacture essential medicines at our Tampa, Florida area location." He further stated that the company is now ready to discuss a full range of partnerships with the industry. Please contact the company to start discussions.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: